Opportunity ID: 331396

General Information

Document Type: Grants Notice
Funding Opportunity Number: W81XWH-21-LCRP-CDA
Funding Opportunity Title: DoD Lung Cancer, Career Development Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Grant
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 3
Assistance Listings: 12.420 — Military Medical Research and Development
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Feb 09, 2021
Last Updated Date: Feb 09, 2021
Original Closing Date for Applications: Apr 20, 2021
Current Closing Date for Applications: Apr 20, 2021
Archive Date: May 20, 2021
Estimated Total Program Funding: $1,200,000
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:

Additional Information

Agency Name: Dept. of the Army — USAMRAA
Description:

 The FY21 LCRP Career Development Award supports early-career, independent investigators to conduct impactful research under the mentorship of an experienced lung cancer researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of lung cancer research. This award is intended to support impactful research projects with an emphasis on discovery.

 

Preliminary data are not required. However, logical reasoning and a sound scientific rationale for the proposed research must be demonstrated.

 

Key elements of this award are as follows:

 

·         Principal Investigator (PI): PIs must be research- or physician-scientists at an early stage of their independent research careers. PIs must be within 5 years of their first faculty appointment (or equivalent) and exhibit a strong desire to pursue a career in lung cancer research.

 

·         Mentorship: The Mentor must be an experienced lung cancer researcher as demonstrated by a strong record of funding and publications in lung cancer research. In addition, the Mentor must demonstrate a commitment to developing the PI’s career in lung cancer research.

 

·         Career Development: A Career Development Plan is required and should be prepared with appropriate guidance from the Mentor. A clearly articulated strategy for acquiring the necessary skills, competence, and expertise to have a career at the forefront of lung cancer research should be included. The plan should outline how the PI will gain experience in lung cancer research. Because career development is the focus of this award, the PI’s institution must demonstrate a commitment to the PI through a minimum of 40% protected time for lung cancer research, though more protected time is highly desirable.

 

·         Impact: Research that has high potential impact may lead to major advancements and significantly accelerate progress toward eradicating deaths and suffering from lung cancer.

·         Relevance to Military Health System Beneficiaries: The application should clearly articulate how the proposed research is relevant to Service members, Veterans, and their families.

 

Relevance to Military Health: The LCRP seeks to support research that is relevant to the healthcare needs of military Service members, Veterans, and their families. Relevance to military health will be considered in determining relevance to the mission of the DHP and FY21 LCRP during programmatic review. Investigators are strongly encouraged to consider the following characteristics as examples of how a project may demonstrate relevance to military health:

·         Use of military or Veteran populations, biospecimens, data/databases, or programs in the proposed research.

 

·         Collaboration with Department of Defense (DoD) or Department of Veterans Affairs (VA) investigators.

 

·         Description of how the knowledge, information, products, or technologies gained from the proposed research could be implemented in a dual-use capacity to address a military need that also benefits the civilian population.

 

·         Explanation of how the project addresses an aspect of lung cancer that has direct relevance to military Service members, Veterans, or other Military Health System beneficiaries, including environmental exposures other than tobacco.

Link to Additional Information:
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

CDMRP Help Desk

Phone: 301-682-5507

Email: help@eBRAP.org
Email:help@eBRAP.org

Version History

Version Modification Description Updated Date

Folder 331396 Full Announcement-FY21 LCRP CDA -> LCRP FY21 CDA PA_GG.pdf

Packages

Agency Contact Information: CDMRP Help Desk
Phone: 301-682-5507
Email: help@eBRAP.org
Email: help@eBRAP.org
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
PKG00265374 Feb 09, 2021 Apr 20, 2021 View

Package 1

Mandatory forms

331396 RR_SF424_3_0-3.0.pdf

331396 AttachmentForm_1_2-1.2.pdf

331396 RR_PersonalData_1_2-1.2.pdf

331396 RR_KeyPersonExpanded_3_0-3.0.pdf

331396 RR_Budget_1_4-1.4.pdf

331396 PerformanceSite_3_0-3.0.pdf

Optional forms

331396 RR_SubawardBudget30_1_4-1.4.pdf

2025-07-11T05:48:02-05:00

Share This Post, Choose Your Platform!

About the Author: